MedPath

ALPRAZOLAM

Approved
Approval ID

747d1977-945d-4f51-b493-757c584fee02

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 11, 2011

Manufacturers
FDA

STAT Rx USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ALPRAZOLAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-447
Application NumberANDA074342
Product Classification
M
Marketing Category
C73584
G
Generic Name
ALPRAZOLAM
Product Specifications
Route of AdministrationORAL
Effective DateNovember 11, 2011
FDA Product Classification

INGREDIENTS (8)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
ALPRAZOLAMActive
Quantity: 0.25 mg in 1 1
Code: YU55MQ3IZY
Classification: ACTIB
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALPRAZOLAM - FDA Drug Approval Details